Researchers looking to buy GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) are investigating one of the most extensively studied copper peptide complexes in the scientific literature. GHK-Cu is a naturally occurring tripeptide-copper(II) complex first isolated from human plasma albumin in the 1970s by Dr. Loren Pickart. With over 50 years of peer-reviewed research, GHK-Cu has one of the richest evidence bases of any research peptide — spanning wound healing, ECM remodelling, antioxidant signalling, and gene expression modulation. EdgeChems supplies GHK-Cu for sale as an HPLC-verified research compound at ≥98% purity.
What Is GHK-Cu?
GHK-Cu (Glycyl-L-Histidyl-L-Lysine: Cu²⁺) is a tripeptide-copper chelate naturally present in human plasma at concentrations that decline significantly with age — from approximately 200 ng/mL in young adults to under 80 ng/mL in those over 60. This age-related decline in circulating GHK-Cu has driven research into whether the peptide plays a role in the deterioration of tissue repair capacity associated with aging.
The copper ion is integral to GHK-Cu’s biological activity. The GHK tripeptide chelates Cu²⁺ in a square planar complex, and this copper-loaded form exhibits markedly different biological activity than the free GHK peptide. The copper facilitates redox chemistry, enzyme cofactor functions, and interactions with extracellular matrix components that the apo-peptide (GHK without Cu) does not replicate.
GHK-Cu Gene Expression Research
One of the most remarkable aspects of GHK-Cu research is the breadth of gene expression changes observed in treated cell cultures. A landmark study by Pickart and Margolina (2018) using Broad Institute LINCS data analysis identified GHK-Cu as capable of modulating the expression of over 4,000 human genes — with particular upregulation of genes associated with:
- Collagen and glycosaminoglycan synthesis
- Antioxidant enzyme expression (superoxide dismutase, catalase)
- Angiogenesis and VEGF signalling
- Nerve outgrowth and neurotrophin expression
- Anti-inflammatory cytokine modulation
This breadth of gene modulation activity distinguishes GHK-Cu from more targeted peptides and has made it a subject of “pleiotropic” aging biology research — the study of single interventions with broad tissue-protective effects.
GHK-Cu in Wound Healing Research
The wound healing properties of GHK-Cu were among the first documented in the scientific literature. Pickart’s original 1973 isolation work was prompted by the observation that GHK-Cu dramatically accelerated liver tissue repair in in vitro organ culture models. Subsequent research established GHK-Cu’s wound healing effects via:
- Collagen synthesis stimulation: GHK-Cu increases collagen type I and III production by fibroblasts in cell culture, a finding replicated in multiple independent laboratories.
- Elastin and proteoglycan upregulation: Beyond collagen, GHK-Cu stimulates elastin synthesis and decorin production — components of the dermal ECM critical for skin elasticity and wound closure.
- Matrix metalloproteinase (MMP) modulation: GHK-Cu exhibits a dual role — upregulating MMPs needed to remove damaged ECM while simultaneously stimulating TIMP (tissue inhibitor of metalloproteinase) expression to prevent excessive degradation.
- Fibroblast proliferation and migration: GHK-Cu at concentrations of 1-100 nM stimulates fibroblast proliferation and directed migration into wound spaces in in vitro models.
AHK-Cu: A Structurally Related Copper Peptide
Researchers studying GHK-Cu may also be interested in AHK-Cu (Alanine-Histidine-Lysine Copper), a structurally related copper tripeptide complex investigated for overlapping and complementary mechanisms. AHK-Cu shares the copper-chelating histidine-lysine motif of GHK-Cu, and is studied for its own collagen biosynthesis and MMP modulation profile. EdgeChems offers AHK-Cu at 100mg per vial — one of the largest vial sizes available for copper peptide research.
KLOW 80: Multi-Peptide Research Stack Including GHK-Cu
For researchers studying GHK-Cu alongside complementary tissue repair peptides, EdgeChems offers the KLOW 80 Blend — a multi-peptide research stack containing GHK-Cu (50mg), TB-500 (10mg), BPC-157 (10mg), and KPV (10mg) in a single 80mg vial. The GHK-Cu component at 62.5% of the blend represents a meaningful research dose for ECM remodelling studies within a multi-pathway tissue repair protocol.
Product Specifications — Buy GHK-Cu From EdgeChems
- Compound: Glycyl-L-Histidyl-L-Lysine: Cu²⁺ (GHK-Cu)
- Format: Liquid solution
- Purity: ≥98% (third-party HPLC verified)
- CAS Number: 89030-95-5
- Molecular Weight: 340.38 g/mol (free peptide)
- Storage: -20°C, protected from light and moisture
- Stability: 24 months sealed; use within 30 days once opened
Order GHK-Cu for sale from EdgeChems with full third-party HPLC COA documentation. Discreet packaging, fast dispatch.
Research Applications Summary
- ECM remodelling and collagen biosynthesis studies
- Wound healing and fibroblast activation research
- MMP and TIMP regulation in skin biology models
- Antioxidant enzyme expression studies
- Angiogenesis and VEGF signalling research
- Anti-aging gene expression and cellular senescence studies
- Hair follicle biology and follicular activation models
For research purposes only. Not intended for human or veterinary use. All information is presented for scientific reference.